PharmAthene (NYSE: PIP) announced that oral arguments in SIGA's appeal and PharmAthene's cross-appeal of the Delaware Court of Chancery's January ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE